Deregulation of NF-кB–miR-146a negative feedback loop may be involved in the pathogenesis of diabetic neuropathy

Journal of Physiology and Biochemistry

Volumn 71, Issue 1, 2015, Pages 51-58

  Yousefzadeh, Nasibeh ^a   Alipour, Mohammad Reza ^a   Ghadiri Soufi, Farhad ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HORMOZGAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes; IRAK1; MicroRNA 146a; NF B; Sciatic nerve; TRAF6

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; MICRORNA 146A; NICOTINAMIDE; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; AUTACOID; GLUCOSE BLOOD LEVEL; INSULIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; IRAK1 PROTEIN, RAT; MESSENGER RNA; MICRORNA; MIRN146 MICRORNA, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETIC NEUROPATHY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE CONTROL; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; HOT PLATE TEST; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; MALE; NEGATIVE FEEDBACK; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PATHOGENESIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SCIATIC NERVE; TAIL IMMERSION TEST; ANIMAL; BLOOD; CASE CONTROL STUDY; CHEMICALLY INDUCED; EXPERIMENTAL DIABETES MELLITUS; GENETICS; GLUCOSE TOLERANCE TEST; METABOLISM; PATHOPHYSIOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CASE-CONTROL STUDIES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; GLUCOSE TOLERANCE TEST; INFLAMMATION MEDIATORS; INSULIN; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; MALE; MICRORNAS; NF-KAPPA B; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SCIATIC NERVE; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 84925535914     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-014-0378-4     Document Type: Article

References (40)

1. Alipour MR, Khamaneh AM, Yousefzadeh N, Mohammad-nejad D, Soufi FG (2013) Upregulation of microRNA-146a was not accompanied by downregulation of pro-inflammatory markers in diabetic kidney. Mol Biol Rep 40:6477–6483
2. Balasubramanyam M, Aravind S, Gokulakrishnan K, Prabu P, Sathishkumar C, Ranjani H, Mohan V (2011) Impaired miR-146a expression links subclinical inflammation and insulin resistance in type 2 diabetes. Mol Cell Biochem 351:197–205
3. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD (2008) MicroRNAs: new regulators of immune cell development and function. Nat Immunol 9:839–945
4. Boldin M, Taganov K, Rao D, Yang L, Zhao J, Kalwani M, Garcia-Flores Y, Luong M, Devrekanli A, Xu J, Sun G, Tay J, Linsley PS, Baltimore D (2011) MiR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med 208:1189–1201
5. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820
6. Cheng H, Sivachandran N, Lau A, Boudreau E, Zhao J, Baltimore D, Delgado-Olguin P, Cybulsky MI, Fish JE (2013) MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways. EMBO Mol Med 5:949–966
7. Chopra K, Tiwari V, Arora V, Kuhad A (2010) Sesamol suppresses neuro-inflammatory cascade in experimental model of diabetic neuropathy. J Pain 11:950–957
8. Edwards JL, Vincent AM, Cheng HT, Feldman EL (2008) Diabetic neuropathy: mechanisms to management. Pharmacol Ther 120:1–34
9. Feng B, Chen S, McArthur K, Wu Y, Sen S, Ding Q, Feldman RD, Chakrabarti S (2011) miR-146a-Mediated extracellular matrix protein production in chronic diabetes complications. Diabetes 60:2975–2984
10. Forbes JM, Cooper ME (2013) Mechanisms of diabetic complications. Physiol Rev 93:137–188
11. Ganesh Yerra V, Negi G, Sharma SS, Kumar A (2013) Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-kappa B pathways in diabetic neuropathy. Redox Biol 1:394–397
12. Granic I, Dolga AM, Nijholt IM, van Dijk G, Eisel UL (2009) Inflammation and NF-kappa B in Alzheimer’s disease and diabetes. J Alzheimers Dis 16:809–821
13. Kaltschmidt B, Kaltschmidt C (2009) NF-kappaB in the nervous system. Cold Spring Harb Perspect Biol 1:a001271
14. Kamboj SS, Vasishta RK, Sandhir R (2010) N-acetylcysteine inhibits hyperglycemia-induced oxidative stress and apoptosis markers in diabetic neuropathy. J Neurochem 112:77–91
15. Kumar A, Sharma SS (2010) NF-kappa B inhibitory action of resveratrol: a probable mechanism of neuroprotection in experimental diabetic neuropathy. Biochem Biophys Res Commun 394:360–355
16. Lovis P, Roggli E, Laybutt DR, Gattesco S, Yang JY, Widmann C, Abderrahmani A, Regazzi R (2008) Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction. Diabetes 57:2728–2736
17. Ma X, Becker Buscaglia LE, Barker JR, Li Y (2011) MicroRNAs in NF-kappa B signaling. J Mol Cell Biol 3:159–166
18. Mann DL (2011) The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls. Circ Res 108:1133–1145
19. Mattson MP, Camandola S (2001) NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 107:247–254
20. Meffert MK, Baltimore D (2005) Physiological functions for brain NF-kappa B. Trends Neurosci 28:37–43
21. Negi G, Kumar A, Sharma SS (2011) Nrf2 and NF-kappaB modulation by sulforaphane counteracts multiple manifestations of diabetic neuropathy in rats and high glucose-induced changes. Curr Neurovasc Res 8:294–304
22. Palomer X, Capdevila-Busquets E, Alvarez-Guardia D, Barroso E, Pallàs M, Camins A, Davidson MM, Planavila A, Villarroya F, Vázquez-Carrera M (2013) Resveratrol induces nuclear factor-κB activity in human cardiac cells. Int J Cardiol 167:2507–2516
23. Palsamy P, Subramanian S (2008) Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats. Biomed Pharmacother 62:598–605
24. Palsamy P, Subramanian S (2010) Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic β-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats. J Cell Physiol 224:423–432
25. Patel S, Santani D (2009) Role of NF-kappa B in the pathogenesis of diabetes and its associated complications. Pharmacol Rep 61:595–603
26. Quinn S, O’Neill L (2011) A trio of microRNAs that control Toll-like receptor signaling. Int Immunol 23:421–425
27. Rains JL, Jain SK (2011) Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med 50:567–575
28. Ramesh B, Pugalendi KV (2006) Antihyperglycemic effect of umbelliferone in streptozotocin-diabetic rats. J Med Food 9:562–566
29. Ramkaran P, Khan S, Phulukdaree A, Moodley D, Chuturgoon AA (2014) miR-146a polymorphism influences levels of miR-146a, IRAK-1, and TRAF-6 in young patients with coronary artery disease. Cell Biochem Biophys 68:259–266
30. Roggli E, Britan A, Gattesco S, Lin-Marq N, Abderrahmani A, Meda P, Regazzi R (2010) Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells. Diabetes 59:978–986
31. Roghani M, Baluchnejadmojarad T (2010) Mechanisms underlying vascular effect of chronic resveratrol in streptozotocin-diabetic rats. Phytother Res 24:S148–S154
32. Rossetti L, DeFronzo RA, Gherzi R, Stein P, Andraghetti G, Falzetti G, Shulman GI, Klein-Robbenhaar E, Cordera R (1990) Effect of metformin treatment on insulin action in diabetic rats: in vivo and in vitro correlations. Metabolism 39:425–435
33. Sanz AB, Sanchez-Nino MD, Ramos AM, Moreno JA, Santamaria B, Ruiz-Ortega M (2010) NF-kappaB in renal inflammation. J Am Soc Nephrol 21:1254–1262
34. Shanmugam KR, Mallikarjuna K, Reddy KS (2011) Effect of alcohol on blood glucose and antioxidant enzymes in the liver and kidney of diabetic rats. Indian J Pharmacol 43:330–335
35. Singh CK, Kumar A, Hitchcock DB, Fan D, Goodwin R, LaVoie HA, Nagarkatti P, DiPette DJ, Singh US (2011) Resveratrol prevents embryonic oxidative stress and apoptosis associated with diabetic embryopathy and improves glucose and lipid profile of diabetic dam. Mol Nutr Food Res 55:1186–1196
36. Soufi FG, Mohammad-nejad D, Ahmadieh H (2012) Resveratrol improves diabetic retinopathy possibly through oxidative stress - nuclear factor kB - apoptosis pathway. Pharmacol Rep 64:1505–1514
37. Vaz C, Mer AS, Bhattacharya A, Ramaswamy R (2011) MicroRNAs modulate the dynamics of the NF-kB signaling pathway. PLoS One 6:e27774
38. Wang L, Chopp M, Szalad A, Zhang Y, Wang X, Zhang RL, Liu XS, Jia L, Zhang ZG (2014) The role of miR-146a in dorsal root ganglia neurons of experimental diabetic peripheral neuropathy. Neuroscience 259:155–163
39. Wohaieb SA, Godin DV (1987) Alterations in free radical tissue-defense mechanisms in streptozocin-induced diabetes in rat. Effects of insulin treatment. Diabetes 36:1014–1018
40. Zhao JL, Rao DS, O'Connell RM, Garcia-Flores Y, Baltimore D (2013) MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice. Elife 2:e00537